@WSJ 3 years ago Pfizer and BioNTech released new data showing their vaccine was 90.7% effective at preventing symptomatic Covid-19 in a study of children 5 to 11 years old. The companies said the vaccine was found to be safe and tolerable. on.wsj.com
@WSJ 4 years ago The Pfizer-BioNTech vaccine protects against symptomatic Covid-19 for at least six months, according to new findings released by the companies on.wsj.com
@nytimes.com 3 years ago Pfizer and BioNTech release new booster trial results of their Covid vaccine.
@WSJ 4 years ago The Pfizer-BioNTech vaccine protects against symptomatic Covid-19 for at least six months, according to new findings released by the companies on.wsj.com
@nytimes.com 3 years ago F.D.A. Fully Approves Pfizer-BioNTech’s Vaccine, a First for a Covid-19 Shot
@forbes.com 3 years ago Pfizer And BioNTech Claim A Third Covid-19 Booster Shot Is Effective